Lcr35: A probiotic strain used in clinical applications for over 50 years, primarily to restore microbial balance in vaginal, intestinal, and immune systems .
Antibody: A protein produced by the immune system to neutralize pathogens. No studies associate Lcr35 with antibody production or monoclonal antibody development.
Vaginal Health: Inhibits Gardnerella vaginalis by modulating SLPI and enhancing epithelial defenses .
Asthma Prevention: Attenuates airway inflammation via Th2 cytokine suppression (IL-4, IL-5, IL-13) and Treg cell induction .
Antifungal Activity: Reduces Candida albicans adhesion and biofilm formation via DAF-16/FOXO pathway activation .
| Parameter | Placebo Group (n=25) | Lcr35 Group (n=25) | P-value |
|---|---|---|---|
| IBS Severity Score | -109.4 ± 93.1 | -56.8 ± 43.9 | NS |
| Abdominal Pain | -61.0 ± 96.0 | -27.5 ± 31.6 | NS |
| NS = Not significant |